Evidence map›Paper›PMID 39452809›Full record

ArticlePharmacy (Basel, Switzerland)2024

Discrepancy between Subjective and Objective Measurements for the Evaluation of Medication Adherence-A Cross-Sectional Study in Patients with Cardiovascular Diseases.

Motoyasu Miyazaki, Hitomi Hirata, Satoko Takaki, Momoko Misaki, Yukako Mori, Kaoko Tokura, Natsuki Sato, Akio Nakashima, Atsuko Yanagida, Isa Okajima and 2 more

Abstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Motoyasu MiyazakiDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.ORCID 0000-0002-4526-3045
Hitomi HirataDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Satoko TakakiDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Momoko MisakiDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Yukako MoriDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Kaoko TokuraDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Natsuki SatoDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Akio NakashimaDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.ORCID 0009-0003-7953-2949
Atsuko YanagidaGraduate School of Humanities and Life Sciences, Tokyo Kasei University, Tokyo 173-8602, Japan.
Isa OkajimaDepartment of Psychological Counseling, Faculty of Humanities, Tokyo Kasei University, Tokyo 173-8602, Japan.ORCID 0000-0003-3494-4328
Hidenori UrataDepartment of Cardiovascular Diseases, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.
Osamu ImakyureDepartment of Pharmacy, Fukuoka University Chikushi Hospital, Fukuoka 818-8502, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medication adherence is important for the appropriate drug-based treatment in patients with chronic diseases, especially those with cardiovascular diseases (CVDs). The purpose of the present study was to evaluate medication adherence among patients with CVDs using subjective and objective measurements. We enrolled outpatients who visited Fukuoka University Chikushi Hospital from June to December 2022. As a subjective measurement, we used a self-reported questionnaire developed by Ueno et al., which consists of 12 questionnaire items grouped into the following four domains: medication compliance (subjective compliance), collaboration with health care providers (collaboration), willingness to access and use information about medication (willingness), and acceptance to take medication and how taking medication fits a patient's lifestyle (acceptance). The pill counting method was used as an objective measurement to calculate the medication adherence rate; Poor Adherence was defined as a medication adherence rate of <100%. Ninety-four patients were analyzed. No statistically significant differences were observed between the patients in the Good and Poor Adherence groups classified by pill counting, an objective indicator; in the subjective evaluation index Ueno scale scores of subjective compliance, collaboration, willingness, and acceptance domains; and in the total score. A multivariate analysis revealed that obesity (odds ratio, 3.527; 95% confidence interval, 1.387-9.423;

Indexed as

cardiovascular diseasesmedication adherencemedication compliancequestionnaire survey

Identifiers

PMID39452809
PMCPMC11511389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.